Where I see patients (2)
My reviews
Selected research
-
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
Expert opinion on investigational drugs
-
Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
Leukemia & lymphoma
-
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study.
Blood cancer journal
Clinical trials
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multipl...
Safety will be evaluated for the population of participants who received at least one dose of study drug. Treatment-emergent AEs will be graded by the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.
Recruiting
5.0